Please login or register first to view this content.
Ophthalmic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
First Biosimilar to Lucentis Gets FDA Approval
Tebentafusp Gets Priority Review for Metastatic Uveal Melanoma
NSAID Eye Drops May Suffice for Cataract Surgery Prophylaxis
FDA Approves Generic Version of Durezol
Intravitreal Methotrexate Gets Orphan Drug Status for Retinitis Pigmentosa
Faricimab Gets Priority Review for Wet AMD, Diabetic Macular Edema
Atropine Plus Patching Ups Visual Acuity in Amblyopic Eye
Investigational Vitamin A Therapy Gets Breakthrough Tx Status for Stargardt Disease
Current Use of Hormonal Contraceptives May Up Glaucoma Risk
Verkazia Approved for Vernal Keratoconjunctivitis
Genetic Predisposition + High Caffeine Intake Ups Risk of Increased Intraocular Pressure
Systane Hydration Multi-Dose Preservative-Free Formulation Now Available
One-Quarter in Ocular HTN Treatment Study Developed Visual Field Loss
Two Peaks in MIS-C Followed COVID-19 Peaks in the US
Aflibercept Cuts Vision-Threatening Complications of Diabetic Retinopathy
More Tepezza Will Be Available Starting in April
Generic Version of Foscavir Now Available
Generic Version of Azopt Now Available
